Related articles:

Zogenix Inc.: Zogenix to Release Fourth Quarter and Full-Year 2016 Financial Results and Host Conference Call and Webcast on March 9
March 02, 2017

Zogenix Inc.: Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results
August 09, 2016

Zogenix Inc.: Zogenix to Release Second Quarter 2016 Financial Results and Host Conference Call and Webcast on August 9
August 02, 2016

Zogenix Inc.: Zogenix Announces Agreement to Refinance Debt, Further Increasing Company’s Expected 2017 Cash Balance
June 21, 2016

Zogenix Inc.: Zogenix Provides Corporate Update and Reports First Quarter 2016 Financial Results
May 10, 2016

Zogenix Inc.: Zogenix to Release First Quarter 2016 Financial Results and Host Conference Call and Webcast on May 10
May 03, 2016

Zogenix Inc.: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results
March 10, 2016

Zogenix Inc.: Zogenix to Release Fourth Quarter and Full-Year 2015 Financial Results and Host Conference Call and Webcast on March 10
March 04, 2016

Zogenix Inc.: Zogenix Provides Corporate Update and Reports Third Quarter 2015 Financial Results
November 09, 2015

Zogenix Inc.: Zogenix to Release Third Quarter 2015 Financial Results and Host Conference Call & Webcast on November 9
November 02, 2015

Zogenix Inc.: Zogenix Provides Corporate Update and Reports Second Quarter 2015 Financial Results
August 10, 2015

Zogenix Inc.: Zogenix to Release Second Quarter 2015 Financial Results and Host Conference Call & Webcast on August 10
August 03, 2015

Zogenix Inc.: Zogenix Expands Senior Leadership Team to Further Drive Strategic Focus on CNS Disorders and Orphan Drug Development
July 06, 2015

Zogenix Inc.: Zogenix Provides Corporate Update and Reports First Quarter 2015 Financial Results
May 11, 2015

Zogenix Inc.: Zogenix to Release First Quarter 2015 Financial Results and Host Conference Call & Webcast on May 11
May 04, 2015

Zogenix Inc.: Dr. Stephen Farr Appointed as CEO of Zogenix to Lead New Strategic Focus and Advance Late-Stage CNS Product Pipeline
April 27, 2015

Zogenix Inc.: Zogenix Reports Fourth Quarter and Full Year 2014 Financial Results
March 10, 2015

Zogenix Inc.: Zogenix Announces Agreement of Sale of Zohydro(R) ER Business to Pernix for $100 Million at Closing Plus Potential Milestones of $283.5 Million
March 10, 2015

Zogenix Inc.: Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2014 Financial Results
March 02, 2015

Zogenix Inc.: Zogenix Reports Third Quarter 2014 Financial Results
November 06, 2014

Zogenix Inc.: Zogenix Announces Conference Call and Webcast to Present Third Quarter 2014 Financial Results
October 30, 2014

Zogenix Inc.: Zogenix Acquires U.K.-Based Brabant Pharma
October 27, 2014

Zogenix Inc.: Zogenix Reports Second Quarter 2014 Financial Results
August 05, 2014

Zogenix Inc.: Zogenix Announces Conference Call and Webcast to Present Second Quarter 2014 Financial Results
July 22, 2014

Zogenix Inc.: Zogenix Announces Appointment of David Brushwood, J.D., R.Ph., to External Safe Use Board
July 17, 2014

Zogenix Inc.: Zogenix Announces New Patent Valid Through 2032 For DosePro(R) Needle-Free Delivery System
July 14, 2014

Zogenix Inc.: Zogenix Reports First Quarter 2014 Financial Results
May 08, 2014

Zogenix Inc.: Zogenix Announces Conference Call and Webcast to Present First Quarter 2014 Financial Results
April 30, 2014

Zogenix Inc.: Zogenix Appoints James Breitmeyer to Its Board of Directors
March 26, 2014

Zogenix Inc.: Zogenix Reports Fourth Quarter and Full Year 2013 Financial Results
March 05, 2014

Zogenix Inc.: Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2013 Financial Results
February 27, 2014

Zogenix Inc.: Zogenix Announces Preliminary Fourth Quarter 2013 Gross Product Sales
January 13, 2014

Zogenix Inc.: Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
December 17, 2013

Zogenix Inc.: Zogenix and Battelle Expand DosePro Technology Business Agreement
December 03, 2013

Zogenix Inc.: Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters
November 12, 2013